| Lincoln Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531633 |
NSE Symbol : LINCOLN |
P/E(TTM) : 11.48 |
|
ISIN Demat : INE405C01035 |
Div & Yield% : 0.00 |
EPS(TTM) : 48.15 |
|
Book Value(₹) : 378.25 |
Market Cap(₹Cr) : 1,106.74 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 671.03 | 623.23 | 580.55 | 510.31 | 472.08 |
| Other Income | 33.45 | 22.48 | 34.42 | 22.48 | 10.00 |
| Stock Adjustments | 7.44 | -8.84 | 5.70 | 4.24 | 13.57 |
| Total Income | 711.92 | 636.87 | 620.67 | 537.03 | 495.65 |
| EXPENDITURE : | |||||
| Raw Materials | 318.60 | 282.48 | 284.04 | 245.64 | 232.15 |
| Power and Fuel Cost | 11.10 | 11.66 | 11.47 | 10.25 | 8.33 |
| Other Manufacturing Expenses | 31.02 | 27.93 | 23.70 | 19.55 | 16.61 |
| Selling and Administration Expenses | 90.62 | 75.28 | 60.99 | 54.50 | 50.88 |
| Miscellaneous Expenses | 4.26 | 3.10 | 3.24 | 2.28 | 2.50 |
| Employee Benefit Expenses | 125.19 | 112.45 | 102.90 | 93.16 | 79.72 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 131.13 | 123.97 | 134.33 | 111.65 | 105.47 |
| Interest | 1.01 | 1.88 | 1.46 | 2.03 | 1.45 |
| Gross Profit | 130.12 | 122.09 | 132.87 | 109.62 | 104.02 |
| Depreciation | 14.50 | 12.90 | 10.62 | 9.17 | 8.09 |
| Profit Before Tax | 115.62 | 109.19 | 122.25 | 100.45 | 95.93 |
| Current Tax | 27.76 | 25.33 | 25.44 | 25.97 | 25.85 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.03 | 1.52 | 3.49 | 1.59 | 0.72 |
| Reported Net Profit | 87.89 | 82.35 | 93.30 | 72.90 | 69.35 |
| Extraordinary Items | 2.21 | 2.15 | 1.07 | 0.37 | 0.61 |
| Adjusted Net Profit | 85.68 | 80.20 | 92.23 | 72.53 | 68.74 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 585.70 | 507.46 | 417.66 | 348.26 | 282.41 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 4.11 | 4.11 | 3.50 | 3.50 | 3.50 |
| P & L Balance carried down | 669.49 | 585.70 | 507.46 | 417.66 | 348.26 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 18.00 | 18.00 | 15.00 | 15.00 |
| Dividend Per Share(Rs) | 1.80 | 1.80 | 1.80 | 1.50 | 1.50 |
| Earnings Per Share-Unit Curr | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 378.25 | 335.34 | 295.98 | 250.86 | 216.12 |
| Book Value(Adj)-Unit Curr | 378.25 | 335.34 | 295.98 | 250.86 | 216.12 |
